IL-6 can increase the vascular endothelial growth factor (VEGF) expression via the Janus tyrosine kinase/signal transducer and activator of transcription 3 (JAK/STAT3) signaling pathway, thereby promoting growth, invasion and lymphangiogenesis in GC patients (20). This evidence concerns the gene IL6 and gastric cancer.